# ZANAFLEX
> **NDA020397** · New Drug Application · Sponsor: LEGACY PHARMA USA · Approved 1996-11-27
## Drug
- **FDA Application Number:** NDA020397
- **Application type:** New Drug Application
- **Brand name:** ZANAFLEX
- **Generic name:** TIZANIDINE HYDROCHLORIDE
- **Active ingredients:** TIZANIDINE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LEGACY PHARMA USA
- **Manufacturer:** Covis Pharma US, Inc
- **First approval:** 1996-11-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020397)
---
*AI Analytics · CC0 1.0*